{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:12:03Z","timestamp":1788671523374,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019693","name":"Universidade Federal Da Fronteira Sul","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019693","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sarcopenia, characterized by the progressive loss of skeletal muscle mass and strength, is highly prevalent among cancer patients and is strongly associated with poor prognosis. Increasing evidence indicates that overactivation of the purinergic system contributes to a chronic inflammatory state that promotes tumor progression and exacerbates muscle wasting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This narrative review examines how physical exercise may modulate purinergic signaling and inflammation, potentially improving the quality of life of cancer patients with sarcopenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was conducted in the MEDLINE database via PubMed, including articles published between 2008 and 2025, using descriptors such as \u201cpurinergic signaling\u201d, \u201cCD39\u201d, \u201cCD73\u201d, \u201cP2X7 receptor\u201d, \u201cadenosine\u201d, \u201csarcopenia\u201d, \u201cskeletal muscle metabolism\u201d, \u201ccancer\u201d, \u201cinflammation\u201d, and \u201cextracellular ATP\u201d.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Original studies and review articles in English addressing the relationship between purinergic pathways, inflammation, muscle metabolism, and cancer were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Findings suggest that cancer-related sarcopenia is closely linked to systemic inflammation mediated by purinergic pathways, and evidence indicates that exercise may play a pivotal role in mitigating muscle loss and improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00011-026-02331-5","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:15:46Z","timestamp":1788606946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exercise as a modulator of purinergic signaling and inflammation in cancer-associated sarcopenia: a narrative review"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4954-9018","authenticated-orcid":false,"given":"Emeline Moraes","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7622-4381","authenticated-orcid":false,"given":"Vitor Mariano Gon\u00e7alves","family":"Dockhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-6598","authenticated-orcid":false,"given":"Jo\u00e3o Victor Garcia","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5747-0466","authenticated-orcid":false,"given":"Francini","family":"Franscescon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3813-7139","authenticated-orcid":false,"given":"D\u00e9bora Tavares","family":"de Resende e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"2331_CR1","doi-asserted-by":"publisher","first-page":"155533","DOI":"10.1016\/j.metabol.2023.155533","volume":"144","author":"S Yuan","year":"2023","unstructured":"Yuan S, Larsson SC. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023;144:155533. https:\/\/doi.org\/10.1016\/j.metabol.2023.155533.","journal-title":"Metabolism"},{"key":"2331_CR2","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.clnu.2017.07.010","volume":"37","author":"F Pamoukdjian","year":"2018","unstructured":"Pamoukdjian F, Bouillet T, L\u00e9vy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review. Clin Nutr Edinb Scotl. 2018;37:1101\u201313. https:\/\/doi.org\/10.1016\/j.clnu.2017.07.010.","journal-title":"Clin Nutr Edinb Scotl"},{"key":"2331_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1080\/0284186X.2023.2180660","volume":"62","author":"S Jensen","year":"2023","unstructured":"Jensen S, Bloch Z, Quist M, Hansen TTD, Johansen C, Pappot H, et al. Sarcopenia and loss of muscle mass in patients with lung cancer undergoing chemotherapy treatment: a systematic review and meta-analysis. Acta Oncol Stockholm Swed. 2023;62:318\u201328. https:\/\/doi.org\/10.1080\/0284186X.2023.2180660.","journal-title":"Acta Oncol Stockholm Swed"},{"key":"2331_CR4","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/jcsm.12967","volume":"13","author":"C de Jong","year":"2022","unstructured":"de Jong C, Chargi N, Herder GJM, van Haarlem SWA, van der Meer F, van Lindert ASR, et al. The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients. J Cachexia Sarcopenia Muscle. 2022;13:1554\u201364. https:\/\/doi.org\/10.1002\/jcsm.12967.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2331_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00520-024-08532-0","volume":"32","author":"MK Jang","year":"2024","unstructured":"Jang MK, Park S, Raszewski R, Park CG, Doorenbos AZ, Kim S. Prevalence and clinical implications of sarcopenia in breast cancer: a systematic review and meta-analysis. Support Care Cancer. 2024;32:328. https:\/\/doi.org\/10.1007\/s00520-024-08532-0.","journal-title":"Support Care Cancer"},{"key":"2331_CR6","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.3390\/cancers15245856","volume":"15","author":"A Papadopetraki","year":"2023","unstructured":"Papadopetraki A, Giannopoulos A, Maridaki M, Zagouri F, Droufakou S, Koutsilieris M, et al. The role of exercise in cancer-related sarcopenia and sarcopenic obesity. Cancers (Basel). 2023;15:5856. https:\/\/doi.org\/10.3390\/cancers15245856.","journal-title":"Cancers (Basel)"},{"key":"2331_CR7","doi-asserted-by":"publisher","first-page":"8212","DOI":"10.3390\/ijerph19138212","volume":"19","author":"H Wang","year":"2022","unstructured":"Wang H, Huang WY, Zhao Y. Efficacy of exercise on muscle function and physical performance in older adults with sarcopenia: an updated systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19:8212. https:\/\/doi.org\/10.3390\/ijerph19138212.","journal-title":"Int J Environ Res Public Health"},{"key":"2331_CR8","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3390\/jcm9051386","volume":"9","author":"H Makizako","year":"2020","unstructured":"Makizako H, Nakai Y, Tomioka K, Taniguchi Y, Sato N, Wada A, et al. Effects of a multicomponent exercise program in physical function and muscle mass in sarcopenic\/pre-sarcopenic adults. J Clin Med. 2020;9:1386. https:\/\/doi.org\/10.3390\/jcm9051386.","journal-title":"J Clin Med"},{"key":"2331_CR9","doi-asserted-by":"publisher","first-page":"16904","DOI":"10.3390\/ijms242316904","volume":"24","author":"M Marco-Bonilla","year":"2023","unstructured":"Marco-Bonilla M, Fresnadillo M, Largo R, Herrero-Beaumont G, Mediero A. Energy regulation in inflammatory sarcopenia by the purinergic system. Int J Mol Sci. 2023;24:16904. https:\/\/doi.org\/10.3390\/ijms242316904.","journal-title":"Int J Mol Sci"},{"key":"2331_CR10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/cancers14030786","volume":"14","author":"A Cao","year":"2022","unstructured":"Cao A, Ferrucci LM, Caan BJ, Irwin ML. Effect of exercise on sarcopenia among cancer survivors: a systematic review. Cancers (Basel). 2022;14:786. https:\/\/doi.org\/10.3390\/cancers14030786.","journal-title":"Cancers (Basel)"},{"key":"2331_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1159\/000525928","volume":"100","author":"A Surov","year":"2022","unstructured":"Surov A, Meyer H-J, Wienke A. Role of sarcopenia in advanced malignant cutaneous melanoma treated with immunotherapy: a meta-analysis. Oncology. 2022;100:498\u2013504. https:\/\/doi.org\/10.1159\/000525928.","journal-title":"Oncology"},{"key":"2331_CR12","doi-asserted-by":"publisher","first-page":"8075","DOI":"10.7314\/apjcp.2015.16.18.8075","volume":"16","author":"J Chindapasirt","year":"2015","unstructured":"Chindapasirt J. Sarcopenia in cancer patients. Asian Pac J Cancer Prev. 2015;16:8075\u20137. https:\/\/doi.org\/10.7314\/apjcp.2015.16.18.8075.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2331_CR13","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/nu15051193","volume":"15","author":"A-L Couderc","year":"2023","unstructured":"Couderc A-L, Liuu E, Boudou-Rouquette P, Poisson J, Frelaut M, Mont\u00e9gut C, et al. Pre-therapeutic sarcopenia among cancer patients: an up-to-date meta-analysis of prevalence and predictive value during cancer treatment. Nutrients. 2023;15:1193. https:\/\/doi.org\/10.3390\/nu15051193.","journal-title":"Nutrients"},{"key":"2331_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1634\/theoncologist.2017-0255","volume":"23","author":"RD Nipp","year":"2018","unstructured":"Nipp RD, Fuchs G, El-Jawahri A, Mario J, Troschel FM, Greer JA, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist. 2018;23:97\u2013104. https:\/\/doi.org\/10.1634\/theoncologist.2017-0255.","journal-title":"Oncologist"},{"key":"2331_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tipsro.2020.10.001","volume":"16","author":"M Anjanappa","year":"2020","unstructured":"Anjanappa M, Corden M, Green A, Roberts D, Hoskin P, McWilliam A, et al. Sarcopenia in cancer: Risking more than muscle loss. Tech Innov Patient Support Radiat Oncol. 2020;16:50\u20137. https:\/\/doi.org\/10.1016\/j.tipsro.2020.10.001.","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"2331_CR16","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/nu13030761","volume":"13","author":"D Meza-Valderrama","year":"2021","unstructured":"Meza-Valderrama D, Marco E, D\u00e1valos-Yerovi V, Muns MD, Tejero-S\u00e1nchez M, Duarte E, et al. Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer. Nutrients. 2021;13:761. https:\/\/doi.org\/10.3390\/nu13030761.","journal-title":"Nutrients"},{"key":"2331_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","volume":"36","author":"T Cederholm","year":"2017","unstructured":"Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr Edinb Scotl. 2017;36:49\u201364. https:\/\/doi.org\/10.1016\/j.clnu.2016.09.004.","journal-title":"Clin Nutr Edinb Scotl"},{"key":"2331_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169.","journal-title":"Age Ageing"},{"key":"2331_CR19","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.3390\/ijms21175963","volume":"21","author":"C Panicucci","year":"2020","unstructured":"Panicucci C, Raffaghello L, Bruzzone S, Baratto S, Principi E, Minetti C, et al. eATP\/P2X7R Axis: an orchestrated pathway triggering inflammasome activation in muscle diseases. Int J Mol Sci. 2020;21:5963. https:\/\/doi.org\/10.3390\/ijms21175963.","journal-title":"Int J Mol Sci"},{"key":"2331_CR20","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1056\/NEJMra1205750","volume":"367","author":"HK Eltzschig","year":"2012","unstructured":"Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation. N Engl J Med. 2012;367:2322\u201333. https:\/\/doi.org\/10.1056\/NEJMra1205750.","journal-title":"N Engl J Med"},{"key":"2331_CR21","doi-asserted-by":"publisher","first-page":"189443","DOI":"10.1016\/j.bbcan.2025.189443","volume":"1880","author":"X Liu","year":"2025","unstructured":"Liu X, Ding Q, Zhang H, Zhang X, Chen Q, Weng S. The CD39-CD73-adenosine axis: master regulator of immune evasion and therapeutic target in pancreatic ductal adenocarcinoma. Biochim Biophys Acta Rev Cancer. 2025;1880:189443. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189443.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2331_CR22","doi-asserted-by":"publisher","first-page":"111931","DOI":"10.1016\/j.exger.2022.111931","volume":"168","author":"Z Liang","year":"2022","unstructured":"Liang Z, Zhang T, Liu H, Li Z, Peng L, Wang C, et al. Inflammaging: The ground for sarcopenia? Exp Gerontol. 2022;168:111931. https:\/\/doi.org\/10.1016\/j.exger.2022.111931.","journal-title":"Exp Gerontol"},{"key":"2331_CR23","doi-asserted-by":"publisher","first-page":"15039","DOI":"10.3390\/ijms232315039","volume":"23","author":"E Antu\u00f1a","year":"2022","unstructured":"Antu\u00f1a E, Cach\u00e1n-Vega C, Bermejo-Millo JC, Potes Y, Caballero B, Vega-Naredo I, et al. Inflammaging: implications in sarcopenia. Int J Mol Sci. 2022;23:15039. https:\/\/doi.org\/10.3390\/ijms232315039.","journal-title":"Int J Mol Sci"},{"key":"2331_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.maturitas.2016.11.006","volume":"96","author":"G Bano","year":"2017","unstructured":"Bano G, Trevisan C, Carraro S, Solmi M, Luchini C, Stubbs B, et al. Inflammation and sarcopenia: a systematic review and meta-analysis. Maturitas. 2017;96:10\u20135. https:\/\/doi.org\/10.1016\/j.maturitas.2016.11.006.","journal-title":"Maturitas"},{"key":"2331_CR25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344. https:\/\/doi.org\/10.1038\/nature07205.","journal-title":"Nature"},{"key":"2331_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12199-018-0740-1","volume":"23","author":"M Murata","year":"2018","unstructured":"Murata M. Inflammation and cancer. Environ Health Prev Med. 2018;23:50. https:\/\/doi.org\/10.1186\/s12199-018-0740-1.","journal-title":"Environ Health Prev Med"},{"key":"2331_CR27","doi-asserted-by":"publisher","first-page":"811288","DOI":"10.3389\/fnut.2021.811288","volume":"8","author":"G-T Ruan","year":"2021","unstructured":"Ruan G-T, Ge Y-Z, Xie H-L, Hu C-L, Zhang Q, Zhang X, et al. Association between systemic inflammation and malnutrition with survival in patients with cancer sarcopenia-a prospective multicenter study. Front Nutr. 2021;8:811288. https:\/\/doi.org\/10.3389\/fnut.2021.811288.","journal-title":"Front Nutr"},{"key":"2331_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","volume":"57","author":"SS Shachar","year":"2016","unstructured":"Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer Oxf Engl: 1990. 2016;57:58\u201367. https:\/\/doi.org\/10.1016\/j.ejca.2015.12.030.","journal-title":"Eur J Cancer Oxf Engl: 1990"},{"key":"2331_CR29","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.imbio.2013.06.003","volume":"218","author":"MR Galdiero","year":"2013","unstructured":"Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S. Tumor associated macrophages and neutrophils in cancer. Immunobiology. 2013;218:1402\u201310. https:\/\/doi.org\/10.1016\/j.imbio.2013.06.003.","journal-title":"Immunobiology"},{"key":"2331_CR30","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2:e1600200. https:\/\/doi.org\/10.1126\/sciadv.1600200.","journal-title":"Sci Adv"},{"key":"2331_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/cancers13010125","volume":"13","author":"U Kahya","year":"2021","unstructured":"Kahya U, K\u00f6seer AS, Dubrovska A. Amino Acid Transporters on the Guard of Cell Genome and Epigenome. Cancers (Basel). 2021;13:125. https:\/\/doi.org\/10.3390\/cancers13010125.","journal-title":"Cancers (Basel)"},{"key":"2331_CR32","doi-asserted-by":"publisher","first-page":"C1316","DOI":"10.1152\/ajpcell.00114.2011","volume":"301","author":"S Lokireddy","year":"2011","unstructured":"Lokireddy S, Mouly V, Butler-Browne G, Gluckman PD, Sharma M, Kambadur R, et al. Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins. Am J Physiol Cell Physiol. 2011;301:C1316\u20131324. https:\/\/doi.org\/10.1152\/ajpcell.00114.2011.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2331_CR33","doi-asserted-by":"publisher","first-page":"49831","DOI":"10.1074\/jbc.M204291200","volume":"277","author":"B Langley","year":"2002","unstructured":"Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem. 2002;277:49831\u201340. https:\/\/doi.org\/10.1074\/jbc.M204291200.","journal-title":"J Biol Chem"},{"key":"2331_CR34","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jcsm.13073","volume":"14","author":"A Martin","year":"2023","unstructured":"Martin A, Gallot YS, Freyssenet D. Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies. J Cachexia Sarcopenia Muscle. 2023;14:1150\u201367. https:\/\/doi.org\/10.1002\/jcsm.13073.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2331_CR35","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1096\/fj.201700442R","volume":"32","author":"R Kj\u00f8bsted","year":"2018","unstructured":"Kj\u00f8bsted R, Hingst JR, Fentz J, Foretz M, Sanz M-N, Pehm\u00f8ller C, et al. AMPK in skeletal muscle function and metabolism. FASEB J. 2018;32:1741\u201377. https:\/\/doi.org\/10.1096\/fj.201700442R.","journal-title":"FASEB J"},{"key":"2331_CR36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","volume":"18","author":"F Di Virgilio","year":"2018","unstructured":"Di Virgilio F, Sarti AC, Falzoni S, De Marchi E, Adinolfi E. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer. 2018;18:601\u201318. https:\/\/doi.org\/10.1038\/s41568-018-0037-0.","journal-title":"Nat Rev Cancer"},{"key":"2331_CR37","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","volume":"17","author":"B Allard","year":"2020","unstructured":"Allard B, Allard D, Buisseret L, Stagg J. The adenosine pathway in immuno-oncology. Nat Rev Clin Oncol. 2020;17:611\u201329. https:\/\/doi.org\/10.1038\/s41571-020-0382-2.","journal-title":"Nat Rev Clin Oncol"},{"key":"2331_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.coph.2015.04.003","volume":"22","author":"JM Argil\u00e9s","year":"2015","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B, L\u00f3pez-Soriano FJ. Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr Opin Pharmacol. 2015;22:100\u20136. https:\/\/doi.org\/10.1016\/j.coph.2015.04.003.","journal-title":"Curr Opin Pharmacol"},{"key":"2331_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/jcsm.12271","volume":"9","author":"JP Hardee","year":"2018","unstructured":"Hardee JP, Counts BR, Gao S, VanderVeen BN, Fix DK, Koh H-J, et al. Inflammatory signalling regulates eccentric contraction-induced protein synthesis in cachectic skeletal muscle. J Cachexia Sarcopenia Muscle. 2018;9:369\u201383. https:\/\/doi.org\/10.1002\/jcsm.12271.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2331_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-04231-7_1","volume":"186","author":"KS Courneya","year":"2011","unstructured":"Courneya KS, Friedenreich CM. Physical activity and cancer: an introduction. Recent Results Cancer Res. 2011;186:1\u201310. https:\/\/doi.org\/10.1007\/978-3-642-04231-7_1.","journal-title":"Recent Results Cancer Res"},{"key":"2331_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26168011","author":"J Bilski","year":"2025","unstructured":"Bilski J, Szlachcic A, Ptak-Belowska A, Brzozowski T Physical activity, exerkines, and their role in cancer cachexia. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26168011.","journal-title":"Int J Mol Sci"},{"key":"2331_CR42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1249\/JSR.0b013e3181e7da73","volume":"9","author":"SM Phillips","year":"2010","unstructured":"Phillips SM, Winett RA. Uncomplicated resistance training and health-related outcomes: evidence for a public health mandate. Curr Sports Med Rep. 2010;9:208\u201313. https:\/\/doi.org\/10.1249\/JSR.0b013e3181e7da73.","journal-title":"Curr Sports Med Rep"},{"key":"2331_CR43","doi-asserted-by":"publisher","first-page":"e1002852","DOI":"10.1371\/journal.pmed.1002852","volume":"16","author":"MLS de Asteasu","year":"2019","unstructured":"de Asteasu MLS, Mart\u00ednez-Velilla N, Zambom-Ferraresi F, Casas-Herrero \u00c1, Cadore EL, Galbete A, et al Assessing the impact of physical exercise on cognitive function in older medical patients during acute hospitalization: secondary analysis of a randomized trial. PLoS Med. 2019;16:e1002852. https:\/\/doi.org\/10.1371\/journal.pmed.1002852.","journal-title":"PLoS Med"},{"key":"2331_CR44","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3389\/fphys.2018.01135","volume":"9","author":"NR Lazarus","year":"2018","unstructured":"Lazarus NR, Harridge SDR. The inherent human aging process and the facilitating role of exercise. Front Physiol. 2018;9:1135. https:\/\/doi.org\/10.3389\/fphys.2018.01135.","journal-title":"Front Physiol"},{"key":"2331_CR45","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2014.10.029","volume":"159","author":"JA Hawley","year":"2014","unstructured":"Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. Integrative biology of exercise. Cell. 2014;159:738\u201349. https:\/\/doi.org\/10.1016\/j.cell.2014.10.029.","journal-title":"Cell"},{"key":"2331_CR46","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaoncol.2016.6914","volume":"3","author":"KM Mustian","year":"2017","unstructured":"Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 2017;3:961\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6914.","journal-title":"JAMA Oncol"},{"key":"2331_CR47","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1249\/MSS.0000000000000297","volume":"46","author":"KS Courneya","year":"2014","unstructured":"Courneya KS, Segal RJ, McKenzie DC, Dong H, Gelmon K, Friedenreich CM, et al. Effects of exercise during adjuvant chemotherapy on breast cancer outcomes. Med Sci Sports Exerc. 2014;46:1744\u201351. https:\/\/doi.org\/10.1249\/MSS.0000000000000297.","journal-title":"Med Sci Sports Exerc"},{"key":"2331_CR48","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s11357-013-9586-z","volume":"36","author":"EL Cadore","year":"2014","unstructured":"Cadore EL, Casas-Herrero A, Zambom-Ferraresi F, Idoate F, Millor N, G\u00f3mez M, et al. Multicomponent exercises including muscle power training enhance muscle mass, power output, and functional outcomes in institutionalized frail nonagenarians. Age (Dordr) Dordrecht Neth. 2014;36:773\u201385. https:\/\/doi.org\/10.1007\/s11357-013-9586-z.","journal-title":"Age (Dordr) Dordrecht Neth"},{"key":"2331_CR49","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","volume":"51","author":"KL Campbell","year":"2019","unstructured":"Campbell KL, Winters-Stone K, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51:2375\u201390. https:\/\/doi.org\/10.1249\/MSS.0000000000002116.","journal-title":"Med Sci Sports Exerc"},{"key":"2331_CR50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12967-026-07690-5","volume":"24","author":"S Wei","year":"2026","unstructured":"Wei S, Lv X, Xu Y, Ding S. Exercise-modulated IL\u20136 in cancer cachexia: molecular mechanisms and therapeutic potential. J Transl Med . 2026;24:162. https:\/\/doi.org\/10.1186\/s12967-026-07690-5.","journal-title":"J Transl Med"},{"key":"2331_CR51","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/eci.12781","volume":"47","author":"BK Pedersen","year":"2017","unstructured":"Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Invest. 2017;47:600\u201311. https:\/\/doi.org\/10.1111\/eci.12781.","journal-title":"Eur J Clin Invest"},{"key":"2331_CR52","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","volume":"88","author":"BK Pedersen","year":"2008","unstructured":"Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin\u20136. Physiol Rev. 2008;88:1379\u2013406. . https:\/\/doi.org\/10.1152\/physrev.90100.2007.","journal-title":"Physiol Rev"},{"key":"2331_CR53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11302-023-09950-1","volume":"20","author":"E de Resende","year":"2024","unstructured":"de Resende E, Silva DT, Bizuti MR, de Oliveira NR, Lima LZM, Dos Santos Arraes VG, Zietz ACG, et al. Physical exercise as a modulator of the purinergic system in the control of sarcopenia in individuals with chronic kidney disease on hemodialysis. Purinergic Signal. 2024;20:213\u201322. https:\/\/doi.org\/10.1007\/s11302-023-09950-1.","journal-title":"Purinergic Signal"},{"key":"2331_CR54","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","volume":"19","author":"L Antonioli","year":"2013","unstructured":"Antonioli L, Pacher P, Vizi ES, Hask\u00f3 G. CD39 and CD73 in immunity and inflammation. Trends Mol Med. 2013;19:355\u201367. https:\/\/doi.org\/10.1016\/j.molmed.2013.03.005.","journal-title":"Trends Mol Med"},{"key":"2331_CR55","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fphar.2017.00661","volume":"8","author":"G Burnstock","year":"2017","unstructured":"Burnstock G. Purinergic signalling: therapeutic developments. Front Pharmacol. 2017;8:661. https:\/\/doi.org\/10.3389\/fphar.2017.00661.","journal-title":"Front Pharmacol"},{"key":"2331_CR56","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/ijc.30380","volume":"139","author":"A Giannuzzo","year":"2016","unstructured":"Giannuzzo A, Saccomano M, Napp J, Ellegaard M, Alves F, Novak I. Targeting of the P2X7 receptor in pancreatic cancer and stellate cells. Int J Cancer. 2016;139:2540\u201352. https:\/\/doi.org\/10.1002\/ijc.30380.","journal-title":"Int J Cancer"},{"key":"2331_CR57","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11302-021-09816-4","volume":"17","author":"AM Cardoso","year":"2021","unstructured":"Cardoso AM, Silv\u00e9rio MNO, de Oliveira Maciel SFV. Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review. Purinergic Signal. 2021;17:649\u201379. https:\/\/doi.org\/10.1007\/s11302-021-09816-4","journal-title":"Purinergic Signal"},{"key":"2331_CR58","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/icb.2017.8","volume":"95","author":"D Allard","year":"2017","unstructured":"Allard D, Turcotte M, Stagg J. Targeting A2 adenosine receptors in cancer. Immunol Cell Biol. 2017;95:333\u20139. https:\/\/doi.org\/10.1038\/icb.2017.8.","journal-title":"Immunol Cell Biol"},{"key":"2331_CR59","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","volume":"98","author":"PA Borea","year":"2018","unstructured":"Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K. Pharmacology of adenosine receptors: the state of the art. Physiol Rev. 2018;98:1591\u2013625. https:\/\/doi.org\/10.1152\/physrev.00049.2017.","journal-title":"Physiol Rev"},{"key":"2331_CR60","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/jcsm.13225","volume":"14","author":"Y Shen","year":"2023","unstructured":"Shen Y, Shi Q, Nong K, Li S, Yue J, Huang J, et al. Exercise for sarcopenia in older people: a systematic review and network meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14:1199\u2013211. https:\/\/doi.org\/10.1002\/jcsm.13225.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"2331_CR61","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","volume":"88","author":"BK Pedersen","year":"2008","unstructured":"Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008;88(4):1379\u2013406.","journal-title":"Physiol Rev"},{"key":"2331_CR62","doi-asserted-by":"publisher","first-page":"101341","DOI":"10.1016\/j.arr.2021.101341","volume":"68","author":"FS Lira","year":"2021","unstructured":"Lira FS, et al. Immunometabolic responses according to physical fitness status and lifelong exercise during aging: new roads for exercise immunology. Ageing Res Rev. 2021;68:101341.","journal-title":"Ageing Res Rev"},{"issue":"11","key":"2331_CR63","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","volume":"51","author":"KL Campbell","year":"2019","unstructured":"Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: consensus statement from an international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375\u201390.","journal-title":"Med Sci Sports Exerc"},{"key":"2331_CR64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12967-021-02737-1","volume":"19","author":"C Harper","year":"2021","unstructured":"Harper C, Gopalan V, Goh J. Exercise rescues mitochondrial coupling in aged skeletal muscle: a comparison of different modalities in preventing sarcopenia. J Transl Med. 2021;19:71.","journal-title":"J Transl Med"},{"issue":"8","key":"2331_CR65","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/eci.12781","volume":"47","author":"BK Pedersen","year":"2017","unstructured":"Pedersen BK. Anti-inflammatory effects of exercise: role in chronic disease prevention. Eur J Clin Invest. 2017;47(8):600\u201311.","journal-title":"Eur J Clin Invest"},{"key":"2331_CR66","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11010-021-04264-5","volume":"477","author":"L Magliulo","year":"2022","unstructured":"Magliulo L, Bondi D, Pini N, et al. The wonder exerkines\u2014novel insights: a critical state-of-the-art review. Mol Cell Biochem. 2022;477:105\u201313.","journal-title":"Mol Cell Biochem"},{"key":"2331_CR67","first-page":"1197907","volume":"10","author":"Y Shen","year":"2023","unstructured":"Shen Y, Chen J, Wang X, et al. Comparative effectiveness of exercise interventions for sarcopenia in older adults: a systematic review and network meta-analysis. Front Med. 2023;10:1197907.","journal-title":"Front Med"},{"key":"2331_CR68","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xie N, Illes P, et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Therapy. 2021;6:162.","journal-title":"Signal Transduct Target Therapy"},{"issue":"23","key":"2331_CR69","doi-asserted-by":"publisher","first-page":"16904","DOI":"10.3390\/ijms242316904","volume":"24","author":"A Mediero","year":"2023","unstructured":"Mediero A, et al. Energy regulation in inflammatory sarcopenia by the purinergic system. Int J Mol Sci. 2023;24(23):16904.","journal-title":"Int J Mol Sci"},{"key":"2331_CR70","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11302-022-09885-z","volume":"19","author":"MJ Wang","year":"2023","unstructured":"Wang MJ, Yang BR, Jing XY, et al. P2Y1R and P2Y2R: potential molecular triggers in muscle regeneration. Purinergic Signalling. 2023;19:305\u201313.","journal-title":"Purinergic Signalling"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02331-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:20:41Z","timestamp":1788668441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02331-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2331"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02331-5","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"195"}}